Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders

Bank of New York Mellon Corp > RARE

DateNameTickerSharesChangeValueChangePrice
06/30/2023Ultragenyx Pharmaceutical Inc.RARE642,986-8,72429,660,928,0003,527,364,000$46,129.97
03/31/2023Ultragenyx Pharmaceutical Inc.RARE651,710-3426,133,564,000-4,061,736,000$40,099.99
12/31/2022Ultragenyx Pharmaceutical Inc.RARE651,744651,74430,195,300,00030,195,300,000$46,330.00
09/30/2022Ultragenyx Pharmaceutical Inc.RARE0-794,0320-47,371,000 
06/30/2022Ultragenyx Pharmaceutical Inc.RARE794,03239,00047,371,000-7,458,000$59.66
03/31/2022Ultragenyx Pharmaceutical Inc.RARE755,032-94,51154,829,000-16,609,000$72.62
12/31/2021Ultragenyx Pharmaceutical Inc.RARE849,543-14,80271,438,000-6,516,000$84.09
09/30/2021Ultragenyx Pharmaceutical Inc.RARE864,3454,48877,954,000-4,035,000$90.19
06/30/2021Ultragenyx Pharmaceutical Inc.RARE859,857101,22581,989,000-23,027,000$95.35
03/31/2021Ultragenyx Pharmaceutical Inc.RARE0-758,6320-105,016,000 
12/31/2020Ultragenyx Pharmaceutical Inc.RARE758,632-13,757105,016,00041,534,000$138.43
09/30/2020Ultragenyx Pharmaceutical Inc.RARE772,38917,24063,482,0004,414,000$82.19
06/30/2020Ultragenyx Pharmaceutical Inc.RARE755,14950,73359,068,00027,771,000$78.22
03/31/2020Ultragenyx Pharmaceutical Inc.RARE704,416473,59831,297,00021,439,000$44.43
12/31/2019Ultragenyx Pharmaceutical Inc.RARE230,8184,5729,858,000179,000$42.71
09/30/2019Ultragenyx Pharmaceutical Inc.RARE226,246-1,9609,679,000-4,812,000$42.78
06/30/2019Ultragenyx Pharmaceutical Inc.RARE228,206-48814,491,000-1,372,000$63.50
03/31/2019Ultragenyx Pharmaceutical Inc.RARE228,69420,76815,863,0006,823,000$69.36
12/31/2018Ultragenyx Pharmaceutical Inc.RARE207,9266619,040,000-6,782,000$43.48
09/30/2018Ultragenyx Pharmaceutical Inc.RARE207,265-39715,822,000-141,000$76.34
06/30/2018Ultragenyx Pharmaceutical Inc.RARE207,6623,90315,963,0005,572,000$76.87
03/31/2018Ultragenyx Pharmaceutical Inc.RARE203,75928,14210,391,0002,245,000$51.00
12/31/2017Ultragenyx Pharmaceutical Inc.RARE175,617-6,9558,146,000-1,577,000$46.39
09/30/2017Ultragenyx Pharmaceutical Inc.RARE182,5726,7369,723,000-1,198,000$53.26
06/30/2017Ultragenyx Pharmaceutical Inc.RARE175,836-9,67610,921,000-1,653,000$62.11
03/31/2017Ultragenyx Pharmaceutical Inc.RARE185,51210,45012,574,000265,000$67.78
12/31/2016Ultragenyx Pharmaceutical Inc.RARE175,06210,18612,309,000614,000$70.31
09/30/2016Ultragenyx Pharmaceutical Inc.RARE164,876164,87611,695,00011,695,000$70.93
06/30/2016Ultragenyx Pharmaceutical Inc.RARE171,436-5,3338,385,000-2,806,000$48.91
03/31/2016Ultragenyx Pharmaceutical Inc.RARE176,76943311,191,000-8,590,000$63.31
12/31/2015Ultragenyx Pharmaceutical Inc.RARE176,3361,55619,781,0002,948,000$112.18
09/30/2015Ultragenyx Pharmaceutical Inc.RARE174,7806,33216,833,000-415,000$96.31
06/30/2015Ultragenyx Pharmaceutical Inc.RARE168,448138,48817,248,00015,903,000$102.39
03/31/2015Ultragenyx Pharmaceutical Inc.RARE81,67716,6275,071,0002,216,000$62.09
12/31/2014Ultragenyx Pharmaceutical Inc.RARE65,050-27,3342,855,000-2,374,000$43.89
<< Prev     Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy